Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay

BACKGROUND: We explore severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow immunoassay (LFIA) performance under field conditions compared to laboratory-based electrochemiluminescence immunoassay (ECLIA) and live virus neutralization. METHODS: In July 2021, 3758 partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Atchison, Christina J, Moshe, Maya, Brown, Jonathan C, Whitaker, Matthew, Wong, Nathan C K, Bharath, Anil A, McKendry, Rachel A, Darzi, Ara, Ashby, Deborah, Donnelly, Christl A, Riley, Steven, Elliott, Paul, Barclay, Wendy S, Cooke, Graham S, Ward, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384551/
https://www.ncbi.nlm.nih.gov/pubmed/35913410
http://dx.doi.org/10.1093/cid/ciac629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384551/
https://www.ncbi.nlm.nih.gov/pubmed/35913410
http://dx.doi.org/10.1093/cid/ciac629

Ejemplares similares